Type I interferons produced by hematopoietic cells protect mice against lethal infection by mammalian reovirus

被引:61
作者
Johansson, Cecilia
Wetzel, J. Denise
He, JianPing
Mikacenic, Carmen
Dermody, Terence S.
Kelsall, Brian L.
机构
[1] NIAID, NIH, Lab Mol Immunol, Bethesda, MD 20892 USA
[2] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Sch Med, Elizabeth B Lamb Ctr Pediat Res, Nashville, TN 37232 USA
关键词
D O I
10.1084/jem.20061587
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We defined the function of type I interferons (IFNs) in defense against reovirus strain type 1 Lang (T1L), which is a double-stranded RNA virus that infects Peyer's patches (PPs) after peroral inoculation of mice. T1L induced expression of mRNA for IFN-alpha, IFN-beta, and Mx-1 in PPs and caused localized intestinal infection that was cleared in 10 d. In contrast, T1L produced fatal systemic infection in IFN alpha R1 knockout (KO) mice with extensive cell loss in lymphoid tissues and necrosis of the intestinal mucosa. Studies of bone-marrow chimeric mice indicated an essential role for hematopoietic cells in IFN-dependent viral clearance. Dendritic cells (DCs), including conventional DCs (cDCs), were the major source of type I IFNs in PPs of reovirus-infected mice, whereas all cell types expressed the antiviral protein Mx-1. Neither NK cells nor signaling via Toll-like receptor 3 or MyD88 were essential for viral clearance. These data demonstrate a requirement for type I IFNs in the control of an intestinal viral infection and indicate that cDCs are a significant source of type I IFN production in vivo. Therefore, innate immunity in PPs is an essential component of host defense that limits systemic spread of pathogens that infect the intestinal mucosa.
引用
收藏
页码:1349 / 1358
页数:10
相关论文
共 47 条
[1]   Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function [J].
Adachi, O ;
Kawai, T ;
Takeda, K ;
Matsumoto, M ;
Tsutsui, H ;
Sakagami, M ;
Nakanishi, K ;
Akira, S .
IMMUNITY, 1998, 9 (01) :143-150
[2]   Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 [J].
Alexopoulou, L ;
Holt, AC ;
Medzhitov, R ;
Flavell, RA .
NATURE, 2001, 413 (6857) :732-738
[3]   Lack of a role for type I and type II interferons in the resolution of rotavirus-induced diarrhea and infection in mice [J].
Angel, J ;
Franco, MA ;
Greenberg, HB ;
Bass, D .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1999, 19 (06) :655-659
[4]   Interferon regulatory factor-1, interferon-β, and reovirus-induced myocarditis [J].
Azzam-Smoak, K ;
Noah, DL ;
Stewart, MJ ;
Blum, MA ;
Sherry, B .
VIROLOGY, 2002, 298 (01) :20-29
[5]   Rotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factor 3 [J].
Barro, M ;
Patton, JT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (11) :4114-4119
[6]   Junction adhesion molecule is a receptor for reovirus [J].
Barton, ES ;
Forrest, JC ;
Connolly, JL ;
Chappell, JD ;
Liu, Y ;
Schnell, FJ ;
Nusrat, A ;
Parkos, CA ;
Dermody, TS .
CELL, 2001, 104 (03) :441-451
[7]   IFN-αβ promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines [J].
Cho, HJ ;
Hayashi, T ;
Datta, SK ;
Takabayashi, K ;
Van Uden, JH ;
Horner, A ;
Corr, M ;
Raz, E .
JOURNAL OF IMMUNOLOGY, 2002, 168 (10) :4907-4913
[8]  
Clarke C. J. P., 2001, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V1, P117, DOI 10.2174/1568008013341361
[9]   Does Toll-like receptor 3 play a biological role in virus infections? [J].
Edelmann, KH ;
Richardson-Burns, S ;
Alexopoulou, L ;
Tyler, KL ;
Flavell, RA ;
Oldstone, MBA .
VIROLOGY, 2004, 322 (02) :231-238
[10]   T-helper 1 and T-helper 2 cytokine responses in gut-associated lymphoid tissue following enteric reovirus infection [J].
Fan, JY ;
Boyce, CS ;
Cuff, CF .
CELLULAR IMMUNOLOGY, 1998, 188 (01) :55-63